Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:e98
Published online before print August 23, 2007, doi: 10.1161/STROKEAHA.107.491258
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/10/e98    most recent
STROKEAHA.107.491258v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Touzé, E.
Right arrow Articles by Mas, J.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Touzé, E.
Right arrow Articles by Mas, J.-L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Coronary Artery Disease
*Stroke

(Stroke. 2007;38:e98.)
© 2007 American Heart Association, Inc.


Letters to the Editor

Overestimation of Coronary Risk in Stroke Patients

Emmanuel Touzé, MD, PhD

Université Paris-Descartes, Service de Neurologie, EA4055, Centre Hospitalier Sainte-Anne, Paris, France

Olivier Varenne, MD, PhD

Université Paris-Descartes, Service de Cardiologie, APHP, Hôpital Cochin, Paris, France

Jean-Louis Mas, MD

Université Paris-Descartes, Service de Neurologie, EA4055, Centre Hospitalier Sainte-Anne, Paris, France


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

Coronary artery disease (CAD) is usually considered a significant cause of morbidity and mortality in stroke patients, although absolute risk of CAD in stroke/transient ischemic attack patients is still not well known and highest risk patients are not well identified. Dhamoon et al provide interesting data in this field, but we have concerns about the potential for misinterpretation of their conclusions, which are mainly based on risks of composite outcomes, without excluding patients with known CAD at baseline.1

First, including stroke in vascular deaths is questionable because it does not provide precise estimates of cardiac events risk after stroke. Yet, guidelines for assessment of cardiovascular risk, including the NCEP ATP III which the authors refer to, do not consider stroke in the cardiovascular risk.2,3 In our recent meta-analysis of 39 cohort studies (65 996 patients), the absolute risk of myocardial infarction (MI) was 2.2% (95% CI, 1.7 to 2.7) per year and that of nonstroke vascular death was 2.1% (1.9 to 2.4) per year.4 Fatal strokes accounted for 39/86 (45%) of vascular deaths in Dhamoon et al’s study, which explains why the risk of vascular death (17.4% at 5 years; ie, 3.5% per year) was higher than that in our meta-analysis.

Second, looking at MI only, the authors observed 19 nonfatal MI and 17 fatal MI, corresponding to a 5-year risk of 5.4% (3.3 to 7.4). Such a risk cannot be considered a high coronary risk according to guidelines for assessment of cardiovascular risk, which consider coronary . . . [Full Text of this Article]